IMMUNIZATION UPDATE from CDC
CDC releases guidance on current Influenza Vaccine StatusCDC releases guidance on current Influenza Vaccine Status: Interim Influenza Vaccination Recommendations: 2004-05
On October 5, 2004, CDC was notified by Chiron Corporation that none of its influenza vaccine (Fluvirin®) would be available for distribution in the United States for the 2004-05 influenza season. The company indicated that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom, where Chiron's Fluvirin vaccine is produced, has suspended the company's license to manufacture Fluvirin vaccine in its Liverpool facility for 3 months, preventing any release of this vaccine for this influenza season. This will reduce by approximately one half the expected supply of trivalent inactivated vaccine (flu shot) available in the United States for the 2004-05 influenza season.
The remaining supply of influenza vaccine that is expected to be available in the United States this season is about 54 million doses of Fluzone®, manufactured Aventis Pasteur. Of these doses, approximately 30 million doses already have been distributed by Aventis Pasteur. In addition, approximately 1.1 million doses of live attenuated influenza vaccine (LAIV/Flumist®) manufactured by MedImmnune will be available this season.
Because of this urgent situation, CDC, in coordination with its Advisory Committee for Immunization Practices (ACIP), is issuing interim recommendations for influenza vaccination during the 2004-05 season. These interim recommendations were formally recommended by ACIP on October 5, 2004 and take precedence over earlier recommendations.
APhA strongly encourages pharmacists and their contractors who are in possession of influenza vaccine to ensure that the vaccine is administered to patients at greatest risk of complications if they get the flu, in accordance with CDC guidelines. A list of those individuals appear below and can be found at :
Who Should Be Vaccinated With the Flu Shot This Season
Priority groups for vaccination with inactivated influenza vaccine this season are:
Other Vaccination Recommendations
Vaccination of Persons in Non Priority Groups
Who Should Not Get Flu Vaccine
People in the following groups should not get flu vaccine before talking with their doctor:
It is prudent to avoid vaccination in people who previously developed Guillain-Barré syndrome (GBS) the 6 weeks after getting a flu shot
For more information, visit www.cdc.gov/flu
For further information contact Mitchel C. Rothholz, APhA, Vice President, Professional Practice at firstname.lastname@example.org (202-429-7549)
CDC has information on its website about non-vaccine strategies for reducing risk of flu:
Brought to you by the American Pharmacists Association
October 27, 2016
October 27, 2016
November 6, 2016
Makoy Center, Hilliard
November 18, 2016
April 21-23, 2017
Greater Columbus Convention Center, Columbus, OH